LUMAKRAS
Live / Registered — Registered (as of 14 Sept 2021)
What this means for you
Registered since 14 Sept 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 14 Sept 2027, and its filing window is open now).
Record
- Serial number
- 90044720
- Registration number
- 6487719
- Mark type
- Word mark
- Filed
- 09 Jul 2020
- Published for opposition
- 29 Sept 2020
- Registered
- 14 Sept 2021
- Next maintenance filing
- §8 declaration of use, due by 14 Sept 2027 (grace period to 14 Mar 2028)
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for use in the treatment of cancer
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 14 Sept 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 25 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Sept 2021 — REGISTERED-PRINCIPAL REGISTER
- 07 Aug 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Aug 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Jul 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jun 2021 — USE AMENDMENT FILED
- 12 Jul 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Jun 2021 — TEAS STATEMENT OF USE RECEIVED
- 06 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2021 — SOU EXTENSION 1 GRANTED